{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:44Z","timestamp":1792592564005,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth differentiation factor 15 (GDF15) is an endocrine hormone belonging to the TGF\u03b2 superfamily member. GDF15 administration or GDF15 overexpression has been reported to have anti-obesity and anti-diabetic effects. Although non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH) is frequently associated with obesity and insulin resistance, the functional role of endogenous GDF15 and therapeutic effect of GDF15 overexpression in NASH and related metabolic deterioration have not been evaluated. Here, we found that GDF15 expression was increased in the livers of NASH animal models and human subjects with NASH. Elevated expression of GDF15 was due to diet-induced hepatic endoplasmic reticulum (ER) stress. <jats:italic>Gdf15<\/jats:italic>-knockout mice exhibited aggravated NASH phenotypes such as increased steatosis, hepatic inflammation, fibrosis, liver injury, and metabolic deterioration. Furthermore, GDF15 directly suppressed expression of fibrosis-related genes and osteopontin (OPN), contributing factors for NASH-related fibrosis, in hepatic stellate cells <jats:italic>in vitro<\/jats:italic> and in the liver of mice <jats:italic>in vivo<\/jats:italic>. Finally, we found that <jats:italic>GDF15<\/jats:italic>-transgenic mice showed attenuation of NASH phenotypes and metabolic deterioration. Therefore, our results suggest that induction of endogenous GDF15 is a compensatory mechanism to protect against the progression of NASH and that GDF15 could be an attractive therapeutic candidate for treatment of NASH and NASH-related metabolic deterioration.<\/jats:p>","DOI":"10.1038\/s41598-018-25098-0","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T08:57:23Z","timestamp":1524646643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Kook Hwan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-8389","authenticated-orcid":false,"given":"Young Suk","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-4942","authenticated-orcid":false,"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3292-1720","authenticated-orcid":false,"given":"Myung-Shik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"25098_CR1","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023, https:\/\/doi.org\/10.1002\/hep.25762 (2012).","journal-title":"Hepatology"},{"key":"25098_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10, 656\u2013665, https:\/\/doi.org\/10.1038\/nrgastro.2013.183 (2013).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"25098_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10, 330\u2013344, https:\/\/doi.org\/10.1038\/nrgastro.2013.41 (2013).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"25098_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso, G., Cassader, M. & Gambino, R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov 15, 249\u2013274, https:\/\/doi.org\/10.1038\/nrd.2015.3 (2016).","journal-title":"Nat Rev Drug Discov"},{"key":"25098_CR5","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","volume":"20","author":"EC Hsiao","year":"2000","unstructured":"Hsiao, E. C. et al. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20, 3742\u20133751 (2000).","journal-title":"Mol Cell Biol"},{"key":"25098_CR6","doi-asserted-by":"publisher","first-page":"33384","DOI":"10.1074\/jbc.M101814200","volume":"276","author":"SJ Baek","year":"2001","unstructured":"Baek, S. J., Horowitz, J. M. & Eling, T. E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 276, 33384\u201333392, https:\/\/doi.org\/10.1074\/jbc.M101814200 (2001).","journal-title":"J Biol Chem"},{"key":"25098_CR7","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov, M. R. et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94, 11514\u201311519 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"25098_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","volume":"1354","author":"R Hromas","year":"1997","unstructured":"Hromas, R. et al. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354, 40\u201344 (1997).","journal-title":"Biochim Biophys Acta"},{"key":"25098_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","volume":"203","author":"LN Lawton","year":"1997","unstructured":"Lawton, L. N. et al. Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 203, 17\u201326 (1997).","journal-title":"Gene"},{"key":"25098_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/carcin\/bgi268","volume":"27","author":"SH Lee","year":"2006","unstructured":"Lee, S. H. et al. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 27, 972\u2013981, https:\/\/doi.org\/10.1093\/carcin\/bgi268 (2006).","journal-title":"Carcinogenesis"},{"key":"25098_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung, H. K. et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J Cell Biol 216, 149\u2013165, https:\/\/doi.org\/10.1083\/jcb.201607110 (2017).","journal-title":"J Cell Biol"},{"issue":"Suppl 1","key":"25098_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ggi.12724","volume":"16","author":"Y Fujita","year":"2016","unstructured":"Fujita, Y., Taniguchi, Y., Shinkai, S., Tanaka, M. & Ito, M. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatr Gerontol Int 16(Suppl 1), 17\u201329, https:\/\/doi.org\/10.1111\/ggi.12724 (2016).","journal-title":"Geriatr Gerontol Int"},{"key":"25098_CR13","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh, J. B. et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 100, 3410\u20133415, https:\/\/doi.org\/10.1073\/pnas.0530278100 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"25098_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/EJE-12-0466","volume":"167","author":"T Kempf","year":"2012","unstructured":"Kempf, T. et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol 167, 671\u2013678, https:\/\/doi.org\/10.1530\/eje-12-0466 (2012).","journal-title":"Eur J Endocrinol"},{"key":"25098_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mito.2014.10.006","volume":"20","author":"Y Fujita","year":"2015","unstructured":"Fujita, Y. et al. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases. Mitochondrion 20, 34\u201342, https:\/\/doi.org\/10.1016\/j.mito.2014.10.006 (2015).","journal-title":"Mitochondrion"},{"key":"25098_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","volume":"50","author":"T Kempf","year":"2007","unstructured":"Kempf, T. et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50, 1054\u20131060, https:\/\/doi.org\/10.1016\/j.jacc.2007.04.091 (2007).","journal-title":"J Am Coll Cardiol"},{"key":"25098_CR17","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1681\/ASN.2016080919","volume":"28","author":"V Nair","year":"2017","unstructured":"Nair, V. et al. Growth Differentiation Factor-15 and Risk of CKD Progression. J Am Soc Nephrol 28, 2233\u20132240, https:\/\/doi.org\/10.1681\/asn.2016080919 (2017).","journal-title":"J Am Soc Nephrol"},{"key":"25098_CR18","doi-asserted-by":"publisher","first-page":"e0127518","DOI":"10.1371\/journal.pone.0127518","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. PLoS One 10, e0127518, https:\/\/doi.org\/10.1371\/journal.pone.0127518 (2015).","journal-title":"PLoS One"},{"key":"25098_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5009\/gnl16049","volume":"11","author":"ES Lee","year":"2017","unstructured":"Lee, E. S. et al. Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity. Gut Liver 11, 276\u2013282, https:\/\/doi.org\/10.5009\/gnl16049 (2017).","journal-title":"Gut Liver"},{"key":"25098_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13587","author":"BK Koo","year":"2017","unstructured":"Koo, B. K. et al. Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease. Liver Int. https:\/\/doi.org\/10.1111\/liv.13587 (2017).","journal-title":"Liver Int"},{"key":"25098_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis, K. et al. NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond) 38, 1555\u20131564, https:\/\/doi.org\/10.1038\/ijo.2014.27 (2014).","journal-title":"Int J Obes (Lond)"},{"key":"25098_CR22","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 13, 1333\u20131340, https:\/\/doi.org\/10.1038\/nm1677 (2007).","journal-title":"Nat Med"},{"key":"25098_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/gutjnl-2011-301146","volume":"62","author":"S Affo","year":"2013","unstructured":"Affo, S. et al. Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis. Gut 62, 452\u2013460, https:\/\/doi.org\/10.1136\/gutjnl-2011-301146 (2013).","journal-title":"Gut"},{"key":"25098_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jhep.2012.05.013","volume":"57","author":"K Tomita","year":"2012","unstructured":"Tomita, K. et al. p53\/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol 57, 837\u2013843, https:\/\/doi.org\/10.1016\/j.jhep.2012.05.013 (2012).","journal-title":"J Hepatol"},{"key":"25098_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/carcin\/23.3.425","volume":"23","author":"SJ Baek","year":"2002","unstructured":"Baek, S. J., Wilson, L. C. & Eling, T. E. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425\u2013434 (2002).","journal-title":"Carcinogenesis"},{"key":"25098_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1053\/j.gastro.2007.10.039","volume":"134","author":"P Puri","year":"2008","unstructured":"Puri, P. et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134, 568\u2013576, https:\/\/doi.org\/10.1053\/j.gastro.2007.10.039 (2008).","journal-title":"Gastroenterology"},{"key":"25098_CR27","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1091\/mbc.E11-06-0510","volume":"22","author":"BF Teske","year":"2011","unstructured":"Teske, B. F. et al. The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress. Mol Biol Cell 22, 4390\u20134405, https:\/\/doi.org\/10.1091\/mbc.E11-06-0510 (2011).","journal-title":"Mol Biol Cell"},{"key":"25098_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2012.09.004","volume":"16","author":"JS So","year":"2012","unstructured":"So, J. S. et al. Silencing of lipid metabolism genes through IRE1alpha-mediated mRNA decay lowers plasma lipids in mice. Cell Metab 16, 487\u2013499, https:\/\/doi.org\/10.1016\/j.cmet.2012.09.004 (2012).","journal-title":"Cell Metab"},{"key":"25098_CR29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","volume":"159","author":"Y Lavin","year":"2014","unstructured":"Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312\u20131326, https:\/\/doi.org\/10.1016\/j.cell.2014.11.018 (2014).","journal-title":"Cell"},{"key":"25098_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","volume":"40","author":"ME Rinella","year":"2004","unstructured":"Rinella, M. E. & Green, R. M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 40, 47\u201351 (2004).","journal-title":"J Hepatol"},{"key":"25098_CR31","doi-asserted-by":"publisher","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","volume":"305","author":"JR Clapper","year":"2013","unstructured":"Clapper, J. R. et al. Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. Am J Physiol Gastrointest Liver Physiol 305, G483\u2013495, https:\/\/doi.org\/10.1152\/ajpgi.00079.2013 (2013).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"25098_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 4, 2823, https:\/\/doi.org\/10.1038\/ncomms3823 (2013).","journal-title":"Nat Commun"},{"key":"25098_CR33","doi-asserted-by":"publisher","first-page":"G264","DOI":"10.1152\/ajpgi.00002.2004","volume":"287","author":"A Sahai","year":"2004","unstructured":"Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M. & Whitington, P. F. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287, G264\u2013273, https:\/\/doi.org\/10.1152\/ajpgi.00002.2004 (2004).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"25098_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.23998","volume":"53","author":"WK Syn","year":"2011","unstructured":"Syn, W. K. et al. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53, 106\u2013115, https:\/\/doi.org\/10.1002\/hep.23998 (2011).","journal-title":"Hepatology"},{"key":"25098_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun, R. et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling. Hepatology 55, 594\u2013608, https:\/\/doi.org\/10.1002\/hep.24701 (2012).","journal-title":"Hepatology"},{"key":"25098_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1182\/blood-2016-01-696617","volume":"128","author":"A Artz","year":"2016","unstructured":"Artz, A., Butz, S. & Vestweber, D. GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5\/TGF-betaRII heterodimer. Blood 128, 529\u2013541, https:\/\/doi.org\/10.1182\/blood-2016-01-696617 (2016).","journal-title":"Blood"},{"key":"25098_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-18-19","volume":"18","author":"MR Preusch","year":"2013","unstructured":"Preusch, M. R. et al. GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis. Eur J Med Res 18, 19, https:\/\/doi.org\/10.1186\/2047-783x-18-19 (2013).","journal-title":"Eur J Med Res"},{"key":"25098_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.carpath.2012.02.003","volume":"21","author":"H Johnen","year":"2012","unstructured":"Johnen, H. et al. Increased expression of the TGF-b superfamily cytokine MIC-1\/GDF15 protects ApoE(\u2212\/\u2212) mice from the development of atherosclerosis. Cardiovasc Pathol 21, 499\u2013505, https:\/\/doi.org\/10.1016\/j.carpath.2012.02.003 (2012).","journal-title":"Cardiovasc Pathol"},{"key":"25098_CR39","doi-asserted-by":"crossref","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med, 10.1038\/nm.4393 (2017).","DOI":"10.1038\/nm.4393"},{"key":"25098_CR40","doi-asserted-by":"publisher","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med, https:\/\/doi.org\/10.1038\/nm.4394 (2017).","DOI":"10.1038\/nm.4394"},{"key":"25098_CR41","doi-asserted-by":"publisher","unstructured":"Mullican, S. E. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med, https:\/\/doi.org\/10.1038\/nm.4392 (2017).","DOI":"10.1038\/nm.4392"},{"key":"25098_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu, J. Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259, https:\/\/doi.org\/10.1038\/nature24042 (2017).","journal-title":"Nature"},{"key":"25098_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17574-w","volume":"7","author":"HK Chung","year":"2017","unstructured":"Chung, H. K. et al. GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury. Sci Rep 7, 17238, https:\/\/doi.org\/10.1038\/s41598-017-17574-w (2017).","journal-title":"Sci Rep"},{"key":"25098_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321, https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"25098_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/labinvest.3780426","volume":"82","author":"B Schnabl","year":"2002","unstructured":"Schnabl, B., Choi, Y. H., Olsen, J. C., Hagedorn, C. H. & Brenner, D. A. Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest 82, 323\u2013333 (2002).","journal-title":"Lab Invest"},{"key":"25098_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.rinim.2014.08.001","volume":"4","author":"H Kitani","year":"2014","unstructured":"Kitani, H. et al. Establishment of c-myc-immortalized Kupffer cell line from a C57BL\/6 mouse strain. Results Immunol 4, 68\u201374, https:\/\/doi.org\/10.1016\/j.rinim.2014.08.001 (2014).","journal-title":"Results Immunol"},{"key":"25098_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Affo, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc 10, 305\u2013315, https:\/\/doi.org\/10.1038\/nprot.2015.017 (2015).","journal-title":"Nat Protoc"},{"key":"25098_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.3014","volume":"19","author":"KH Kim","year":"2013","unstructured":"Kim, K. H. et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 19, 83\u201392, https:\/\/doi.org\/10.1038\/nm.3014 (2013).","journal-title":"Nat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25098-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25098-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25098-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:46:14Z","timestamp":1671597974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25098-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25098"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25098-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"4 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6789"}}